Artivion (NYSE:AORT – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company ...

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham ...

Needham says Calix (CALX) reported Q4 above consensus and guided Q1 higher than expected as the company continues to execute well against its ...

Needham analyst David Saxon raised the firm’s price target on Dentsply Sirona (XRAY) to $25 from $23 and keeps a Buy rating on the shares ahead ...

Alphabet (NASDAQ:GOOG) just got a fresh endorsement from Needham & Company, which raised its price target to $225 from $210.

Calix (NYSE:CALX) shares maintained their Buy rating and $45.00 price target from Needham, following the company's fourth-quarter earnings results. Needham analysts highlighted Calix's revenue and non ...

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst ...

SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced that its financial results for the fourth quarter and fiscal year 2024 will be released on Thursday, ...

Investing.com -- Needham & Company raised its price target for Alphabet to $225 from $210 in a note Monday following interviews with 20 CEOs at CES and the Needham Growth Conference.

Technological innovations in steam power, electricity and microprocessors drove the first industrial revolution.

Needham has recently raised Upstart Holdings Inc (UPST) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 3, 2024, Redburn Atlantic ...

Investing.com -- Needham & Company raised its price target for Alphabet to $225 from $210 in a note Monday following interviews with 20 CEOs at CES and the Needham Growth Conference. The firm also ...